Rivalry Reports Q1 2025 Results Highlighting Strengthened Unit Economics, Operating Leverage, and Strategic Progress Operating expenses reduced 58% YoY and net loss narrowed 43% as Rivalry emerges a lean, high-performance engine built for scale, with Q2 setting new records in key user metrics GlobeNewswire July 14, 2025 TORONTO, July 14, 2025 (GLOBE NEWSWIRE) — Rivalry […]

Marex Group plc to Announce Second Quarter 2025 Results on August 13, 2025 GlobeNewswire July 14, 2025 NEW YORK, July 14, 2025 (GLOBE NEWSWIRE) — Marex Group plc (NASDAQ: MRX), the diversified global financial services platform, today announced that it will release its fiscal 2025 second quarter results before the markets open on Wednesday, August

Shareholders that lost money on XPLR Infrastructure, LP f/k/a Nextera Energy Partners, LP(XIFR) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More GlobeNewswire July 14, 2025 NEW YORK, July 14, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in XPLR Infrastructure, LP f/k/a Nextera Energy Partners, LP (“XPLR Infrastructure,

Investors in Rocket Pharmaceuticals, Inc. Should Contact Levi & Korsinsky Before August 11, 2025 to Discuss Your Rights – RCKT GlobeNewswire July 14, 2025 NEW YORK, July 14, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Rocket Pharmaceuticals, Inc. (“Rocket” or the “Company”) (NASDAQ: RCKT) of a class action securities lawsuit. CLASS

Investors in Centene Corporation Should Contact Levi & Korsinsky Before September 8, 2025 to Discuss Your Rights – CNC GlobeNewswire July 14, 2025 NEW YORK, July 14, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Centene Corporation (“Centene” or the “Company”) (NYSE: CNC) of a class action securities lawsuit. CLASS DEFINITION: The

Sanuwave Health Announces Preliminary Revenue Results for the Second Quarter 2025 (Ended June 30, 2025) GlobeNewswire July 14, 2025 Sanuwave is pleased to announce preliminary revenues of $10.1 million to $10.2 million for the second quarter ended June 30, 2025. This represents the highest Q2 quarterly revenues in Company history. Q2 2025 revenue increased between

NEW YORK, July 14, 2025 (GLOBE NEWSWIRE) — The Dr. Sagy Grinberg Healing Hands Scholarship for Healthcare has officially opened applications for its upcoming award cycle, inviting undergraduate students from across the United States to apply for a one-time scholarship of $1,000. This initiative is designed to support aspiring healthcare professionals who demonstrate not only

DALLAS, July 14, 2025 (GLOBE NEWSWIRE) — The Andrew Hillman Scholarship for Entrepreneurs is now open for applications, offering undergraduate students across the United States a unique opportunity to gain recognition and financial support for their entrepreneurial aspirations. Created by renowned business strategist and investor Andrew Hillman, the scholarship seeks to identify and support students

(NasdaqGM:IOVA), NEW YORK, July 14, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Iovance Biotherapeutics, Inc. (“Iovance” or the “Company”) (NASDAQ: IOVA) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Iovance investors who were adversely affected by alleged securities fraud between May 9,

(NYSE:VSTS), NEW YORK, July 14, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Vestis Corporation (“Vestis” or the “Company”) (NYSE: VSTS) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Vestis investors who were adversely affected by alleged securities fraud between May 2, 2024